Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AnteoTechASX:ADO 3-Year EBITDA Growth Rate is 20.60% as of Dec. 2025, which is 90% above its 10-year median of 10.85. The stock has 4 warning signs investors should review. Among 1,407 Chemicals companies, AnteoTech ranks better than 81.24% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 20.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was -1.90% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was -3.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of AnteoTech was 63.70% per year. The lowest was -26.00% per year. And the median was 10.85% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
AnteoTech 3-Year EBITDA Growth Rate Related Terms
ASX:ADO vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, AnteoTech's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AnteoTech 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, AnteoTech's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where AnteoTech's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 20.60% mean?
AnteoTech (ASX:ADO) has a 3-Year EBITDA Growth Rate of 20.60% as of Dec. 2025. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AnteoTech and its competitors. This is 90% above median its historical median of 10.85. According to the industry distribution chart, AnteoTech ranks #264 out of 1407 companies in the Chemicals industry, placing it in the top 18.8%.
Is AnteoTech's 3-Year EBITDA Growth Rate too high?
AnteoTech's current 3-Year EBITDA Growth Rate of 20.60% is 90% above median its 10-year median of 10.85. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. AnteoTech's value of 20.60% is 2475% above this industry median. Based on the distribution chart, AnteoTech ranks #264 out of 1407 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers.
How does AnteoTech's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, AnteoTech ranks #264 out of 1407 companies for 3-Year EBITDA Growth Rate. This places AnteoTech in the top 19% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. AnteoTech's value of 20.60% is 2475% above this benchmark. While the company's 10-year median is 10.85 vs. the industry median of 0.80, AnteoTech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,407 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AnteoTech's current 3-Year EBITDA Growth Rate of 20.60% is 2475% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for AnteoTech and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AnteoTech's current 3-Year EBITDA Growth Rate is 20.60%, which is 90% above median its own 10-year median of 10.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AnteoTech stock overvalued right now?
AnteoTech (ASX:ADO) has a current 3-Year EBITDA Growth Rate of 20.60%. The current 3-Year EBITDA Growth Rate is 20.60%, which is 90% above median its 10-year median of 10.85 and 2475% above the Chemicals industry median of 0.80. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For AnteoTech (ASX:ADO), the current 3-Year EBITDA Growth Rate is 20.60% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ADO has been successfully added to your 
